Health Canada says a safety review of Fibristal to treat uterine fibroids in women of childbearing age has found a possible link between its use and the risk of a rare liver injury.
Health Canada says a safety review of Fibristal to treat uterine fibroids in women of childbearing age has found a possible link between its use and the risk of a rare liver injury.